Nirma Ltd Sells 2.99% Stake in Alivus Life Sciences via Open Market
Alivus Life Sciences Ltd 路 Acquisition/ Disposal of Shares 路 07 Nov 2026, 8:48 pm
Nirma Ltd Sells 2.99% Stake in Alivus Life Sciences via Open Market Promoter Nirma Ltd sold 36,80,000 equity shares, representing a 2.99% stake, in Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd) via open market transactions on 6th Nov'26. Following the disposal, Nirma Ltd's equity holding in Alivus Life Sciences decreased from 9,18,96,285 shares (74.73% of total voting capital; 74.54% diluted) to 8,82,16,285 shares (71.74% of total voting capital; 71.56% diluted). Total equity share capital remains at 12,29,67,281 shares, with diluted equity capital standing at 12,32,81,979 shares.
Original exchange filing (PDF)
More announcements from Alivus Life Sciences Ltd
- Enclosed please find herewith update on acquisition. 路 11 Nov 2026
- Please find enclosed herewith disclosure under Regulation 30 of SEBI(LODR), 2015. 路 11 Nov 2026
- Please find attached herewith submission with respect to transcript of the earning call. 路 06 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor meeting. 路 04 Nov 2026
- Please find enclosed herewith intimation for Analyst/Investor Meet. 路 30 Oct 2026
- We hereby confirm that we have uploaded audio recording of the Q2 FY2027 Earnings Call held on October 30, 2026 on the website of the Company. 路 30 Oct 2026
- Please find enclosed herewith intimation with respect to allotment of equity shares under "Employee Stock Option Scheme, 2021" 路 30 Oct 2026
- Please find enclosed herewith Investor Presentation for Q2 FY26-27. 路 30 Oct 2026
